Real Talk with Riggin

Medical Watchdog Testifies Before Senate Committee on the Dangers of Gender Transition Surgery with Chief Medical Officer at DO NO HARM Dr. Kurt Miceli

8 min · 8. juni 2026
episode Medical Watchdog Testifies Before Senate Committee on the Dangers of Gender Transition Surgery with Chief Medical Officer at DO NO HARM Dr. Kurt Miceli cover

Description

Medical watchdog organization Do No Harm is bringing renewed attention to the debate over gender transition procedures for minors as its Chief Medical Officer, Dr. Kurt Miceli, testifies before a Senate committee examining the potential risks and long-term consequences of gender transition surgeries. Dr. Miceli is expected to discuss emerging medical evidence, informed consent concerns, and the growing international scrutiny surrounding pediatric gender medicine. The hearing comes amid ongoing national discussions over patient safety, ethics, and the role of government in regulating medical treatments for children and adolescents experiencing gender dysphoria.

Comments

0

Be the first to comment

Sign up now and become a member of the Real Talk with Riggin community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

100 episodes

episode Trump Threatens 500+ Hospitals with Fines for Failing to Meet Price Transparency Requirements with Director of Research for PRA Ilaria Wheeler artwork

Trump Threatens 500+ Hospitals with Fines for Failing to Meet Price Transparency Requirements with Director of Research for PRA Ilaria Wheeler

The Trump administration is stepping up enforcement of federal hospital price transparency rules, threatening more than 500 hospitals with fines for failing to publicly disclose the actual costs of medical services as required by law. Supporters argue that greater transparency empowers patients to compare prices, make informed healthcare decisions, and increase competition in the marketplace, while critics question whether the reporting requirements place additional burdens on healthcare providers. Director of Research for the PRA, Ilaria Wheeler, joins us to discuss why so many hospitals remain out of compliance, what the potential penalties could mean for healthcare systems nationwide, and how increased price transparency may impact patients, providers, and overall healthcare costs.

11. juni 202616 min